Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Primary and secondary safety endpoints from IMPACT II
Neal S. Kleiman
DeBakey Heart & Vascular Center
Academic Institute
Research Institute
Department of Cardiology
Department of Cardiovascular Sciences
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Primary and secondary safety endpoints from IMPACT II'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Eptifibatide
100%
Safety
37%
Hemorrhage
23%
Platelet Glycoprotein GPIIb-IIIa Complex
23%
Angioplasty
18%
Coronary Thrombosis
12%
Platelet Aggregation Inhibitors
10%
Platelet Aggregation
9%
Percutaneous Coronary Intervention
9%
Thrombocytopenia
8%
Anti-Idiotypic Antibodies
7%
Blood Platelets
7%
Emergencies
7%
Placebos
6%
Peptides
5%
Incidence
4%
Therapeutics
1%